World Of Taxonomy
63479-0101Level 3

A01 (ACETICUM ACIDUM, ARNICA MONTANA, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CEANOTHUS AMERICANUS, CERATOSTIGMA ILLMOTTIANUM, CHININUM ARSENICOSUM, CITRICUM ACIDUM, ENGLISH ELM, EUROPEAN HORNBEAM, EUROPEAN OLIVE, GENTIANELLA AMARELLA, HYDROFLUORICUM ACIDUM, JUGLANS REGIA, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRUM SILICOFLUORICUM, NATRUM SULPHURICUM, PASSIFLORA INCARNATA, PHOSPHORICUM ACIDUM, SARCOLACTICUM ACIDUM, SOLIDAGO VIRGAUREA)

**Product type:** Human Otc Drug

**Active ingredient:** ACETIC ACID; ANHYDROUS CITRIC ACID; ARNICA MONTANA; AVENA SATIVA FLOWERING TOP; CALCIUM SULFATE ANHYDROUS; CARPINUS BETULUS FLOWER; CEANOTHUS AMERICANUS LEAF; CERATOSTIGMA WILLMOTTIANUM FLOWER; GENTIANELLA AMARELLA FLOWER; HYDROFLUORIC ACID; JUGLANS REGIA FLOWERING TOP; LACTIC ACID, DL-; LACTIC ACID, L-; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OLEA EUROPAEA FLOWER; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORIC ACID; QUININE ARSENITE; SODIUM CHLORIDE; SODIUM HEXAFLUOROSILICATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; SOLIDAGO VIRGAUREA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; ULMUS PROCERA FLOWERING TWIG

**Strength:** 30; 30; 12; 1; 12; 9; 4; 12; 12; 30; 9; 15; 15; 15; 12; 15; 1; 30; 15; 30; 8; 12; 10; 1; 15; 12 [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL

**Dosage form:** Solution/ Drops

**Route:** Sublingual

**Labeler:** Apex Energetics Inc.

**Marketing category:** UNAPPROVED HOMEOPATHIC

**Pharmacologic class:** Acidifying Activity [MoA], Anti-coagulant [EPC], Antimalarial [EPC], Blood Coagulation Factor [EPC], Calcium Chelating Activity [MoA], Calcium [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Decreased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

GET/api/v1/systems/ndc_fda/nodes/63479-0101
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.